Fluorinated 2-(4-amino-3-methylphenyl) benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells

被引:50
作者
Brantley, E
Trapani, V
Alley, MC
Hose, CD
Bradshaw, TD
Stevens, MFG
Sausville, EA
Stinson, SF
机构
[1] NCI, Biol Testing Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21701 USA
[2] Univ Nottingham, Sch Pharmaceut Sci, Canc Res Labs, Nottingham NG7 2RD, England
[3] Sci Applicat Int Corp, Screening Technol Branch, Dev Therapeut Program, Frederick, MD USA
关键词
D O I
10.1124/dmd.104.001057
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Fluorinated 2-(4-amino-3-methylphenyl) benzothiazoles possess potent antiproliferative activity against certain cancer cells, similar to the unfluorinated 2-(4-amino-3-methylphenyl) benzothiazole (DF 203, NSC 674495). In "sensitive" cancer cells, DF 203 is metabolized by, can induce expression of, and binds covalently to CYP1A1. Metabolism appears to be essential for its antiproliferative activity through DNA adduct formation. However, a biphasic dose-response relationship compromises its straightforward development as a chemotherapeutic agent. We investigated whether fluorinated benzothiazoles inhibit cancer cell growth without the biphasic dose-response, and whether the fluorinated benzothiazoles are also metabolized into reactive species, with binding to macromolecules in sensitive cancer cells. One fluorinated benzothiazole, 2-(4-amino-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) did exhibit potent, antiproliferative activity without a biphasic dose-response. The fluorinated benzothiazoles were also metabolized only in cells, which subsequently showed evidence of cell death. We used microsomes from genetically engineered human B-lymphoblastoid cells expressing cytochromes P450 (CYP1A1, CYP1A2, or CYP1B1) to clarify the basis for fluorinated benzothiazole metabolism. 5F 203 induced CYP1A1 and CYP1B1 mRNA expression in sensitive breast and renal cancer cells, whereas 5F 203 induced CYP1A1 mRNA but not CYP1B1 mRNA expression in sensitive ovarian cancer cells. 5F 203 did not induce CYP1A1 or CYP1B1 mRNA expression in any "resistant" cancer cells. The fluorinated benzothiazoles induced CYP1A1 protein expression exclusively in sensitive cells. [C-14] 5F 203 bound substantially to subcellular fractions in sensitive cells but only minimally in resistant cells. These data are concordant with the antiproliferative activity of fluorinated benzothiazoles deriving from their ability to become metabolized and bind to macromolecules within sensitive cells.
引用
收藏
页码:1392 / 1401
页数:10
相关论文
共 39 条
[1]
Design and synthesis of potent antitumor 5,4'-diaminoflavone derivatives based on metabolic considerations [J].
Akama, T ;
Ishida, H ;
Shida, Y ;
Kimura, U ;
Gomi, K ;
Saito, H ;
Fuse, E ;
Kobayashi, S ;
Yoda, N ;
Kasai, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (12) :1894-1900
[2]
ALLEY MC, 1988, CANCER RES, V48, P589
[3]
ALLEY MC, 2000, P AM ASSOC CANC RES, V41, P813
[4]
In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles [J].
Bradshaw, TD ;
Chua, MS ;
Browne, HL ;
Trapani, V ;
Sausville, EA ;
Stevens, MFG .
BRITISH JOURNAL OF CANCER, 2002, 86 (08) :1348-1354
[5]
Bradshaw TD, 2002, MOL CANCER THER, V1, P239
[6]
The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds [J].
Bradshaw, TD ;
Stevens, MFG ;
Westwell, AD .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (02) :203-210
[7]
2-(4-aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity [J].
Bradshaw, TD ;
Wrigley, S ;
Shi, DF ;
Schultz, RJ ;
Paull, KD ;
Stevens, MFG .
BRITISH JOURNAL OF CANCER, 1998, 77 (05) :745-752
[8]
Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo [J].
Bradshaw, TD ;
Schultz, RJ ;
Paull, KD ;
Kelland, L ;
Wilson, A ;
Garner, C ;
Fiebig, HH ;
Wrigley, S ;
Stevens, MFG .
BRITISH JOURNAL OF CANCER, 1998, 78 (04) :421-429
[9]
Chemical-induced apoptosis: Formation of the Apaf-1 apoptosome [J].
Cain, K .
DRUG METABOLISM REVIEWS, 2003, 35 (04) :337-363
[10]
An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy [J].
Chase, M ;
Chung, RY ;
Chiocca, EA .
NATURE BIOTECHNOLOGY, 1998, 16 (05) :444-448